Questions and answers regarding co-processed excipients used in solid oral dosage forms (H & V)
Human medicines European public assessment report (EPAR): Cialis, tadalafil, Date of authorisation: 12/11/2002, Revision: 33, Status: Authorised
EMA guidance on the use of medicinal products for treatment in case of exposure to chemical agents used as weapons of terrorism, crime, or warfare
EMA guidance on the use of medicinal products for treatment and prophylaxis in case of exposure to biological agents used as weapons of terrorism, crime or warfare
Consolidated 3-year rolling work plan for the Haematology Working Party (HAEMWP) : January 2025 - December 2027
Consolidated 3-year rolling work plan for the Oncology Working Party : January 2025 - December 2027
Draft 3-year rolling work plan for the Rheumatology and Immunology Working Party (RIWP) : 2025-2027
CAT quarterly highlights and approved ATMPs - May-July 2024
Pharmacovigilance Risk Assessment Committee (PRAC): 8-11 July 2024, European Medicines Agency, Amsterdam, the Netherlands, from 8 July 2024 to 11 July 2024
Minutes of the PRAC meeting 8-11 July 2024